Delivery Order 75F40119D10041-75F40126F19018

Dnanexus, Inc. was awarded a $3,419,094.15 firm fixed price delivery order by the Department of Health and Human Services' Food and Drug Administration to provide continued development services for the agency's PrecisionFDA Increment D program. Under this delivery order issued against the company's existing $20 million small business set-aside indefinite delivery contract with the FDA for ongoing PrecisionFDA Collaborative Omics Environment support, Dnanexus will deliver operations, development,...

The Department of Health and Human Services Food and Drug Administration awarded a $954,448.72 delivery order contract to Dnanexus, Inc., doing business as Dnanexus Inc., located in Mountain View, California. The contract period is from February 18, 2022 through February 21, 2023 and utilizes a firm fixed price contract type. Under the terms of the contract, Dnanexus Inc. will provide services to accept Real World Data through PrecisionFDA into the Food and Drug Administration's Intelligent...

This is a delivery order awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit technology company based in Mountain View, California. The contract, valued at $473,879.68, is for the operation and maintenance of the PrecisionFDA public instance of the Genomics Sequence and Regulatory Science (GSRS) platform. PrecisionFDA is a cloud-based genomics data management and analysis platform that enables collaboration between researchers and regulatory reviewers. This delivery...

This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit organization providing cloud-based genomics data management and analysis services. The $796,885.33 contract supports the FDA's PrecisionFDA program, which aims to advance regulatory science through precision medicine approaches. Dnanexus will provide cloud platform services, bioinformatics software, and database services to support the PrecisionFDA collaborative...

The Department of Health and Human Services Food and Drug Administration awarded a $607,840 delivery order to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will provide its cloud-based platform as a service under a firm fixed price contract to support FDA's regulatory science programs. The place of performance will be in Silver Spring, Maryland. The one year contract starts in August 2021 and runs through August 2022 to give FDA researchers access...

The Department of Health and Human Services Food and Drug Administration awarded a $2.232 million delivery order contract to Dnanexus, Inc. to provide a PrecisionFDA Collaborative Omics Environment in the cloud. With a completion date of September 29, 2020 and no set-aside designation, this time and materials contract supports the FDA's efforts to advance regulatory science through an open data sharing platform for multi-omics data analysis. Located in Mountain View, California, Dnanexus will...

The Department of Health and Human Services Food and Drug Administration awarded a $2.8 million firm fixed price delivery order contract to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will deliver its cloud-based precisionFDA platform to support the FDA's regulatory science programs over a one year period of performance ending in September 2022. No subcontractors or set aside designations were identified. This contract leverages Dnanexus' existing...

<p>The Food and Drug Administration issued a $33,175 delivery order to Pacific Biosciences of California, Inc. on August 29, 2023, for sequencing reagents and supplies including AmpureXP, HiFi Express template prep kit, Sequel binding kit, Sequel sequencing kit, and SMRT cell trays.</p> <p>Place of performance is Silver Spring, MD. The order is firm fixed price with an ultimate completion date of March 30, 2024. No set-aside was used.</p>

The Food and Drug Administration awarded a definitive, firm fixed-price contract to DNAnexus, Inc., a Mountain View, California-based cloud-based genomics and regulatory science solutions provider, on September 9, 2024, with a ceiling value of $1.05 million. The contract involves development of the PRISM High-Impact Platform Pilot, a pre-submission validation tool for eCTDs (electronic Common Technical Documents) designed to facilitate sponsor-reviewer interaction within the FDA's regulatory...

This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Precision Nanosystems US Inc., a for-profit small business organization, on August 22, 2022. The contract, valued at $119,600.58, is for the delivery of a NanoAssemblr Ignite bench-top lipid nanoparticle assembler instrument system. The contract has a completion date of October 31, 2023. The contract was set aside for total small business...